---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-067589"
form_type: "8-K"
ticker: "PTGX"
cik: "0001377121"
company_name: "Protagonist Therapeutics, Inc"
filed_at: "2022-06-02T23:59:59+00:00"
generated_at: "2026-06-25T05:04:13.748615+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Protagonist Therapeutics stockholder meeting approves director elections, say-on-pay, and auditor ratification

## Summary
- Harold Selick and Bryan Giraudo elected Class III directors with 27.9M and 28.1M votes for, respectively.
- Advisory say-on-pay approved: 35.8M for, 0.4M against; 2.4M broker non-votes.
- Non-binding vote favored annual say-on-pay frequency (35.6M for 1 year); company intends annual votes.
- Ernst & Young ratified as auditor for FY2022: 38.7M for, 5.6K against, 1.5K abstain.

## SEC filing metadata
- accession: 0001104659-22-067589
- form_type: 8-K
- ticker: PTGX
- cik: 0001377121
- company_name: Protagonist Therapeutics, Inc
- filed_at: 2022-06-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1377121/000110465922067589/0001104659-22-067589-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1377121/000110465922067589/tm2217556d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-067589
- JSON: https://secwatch.observer/filing/0001104659-22-067589.json
- Plain text: https://secwatch.observer/filing/0001104659-22-067589.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.